Marta Corral Blanco
Madrid, 28041, Spain
NCT Number: NCT06457399
Heliox (a mixture of Helium and Oxygen) can reduce the work of breathing in patients with airway stenosis by modifying turbulent flow into laminar flow. The aim of this study was to analyze the effect of Heliox versus conventional oxygen therapy in patients with lower airway stenosis on muscular effort measured by electromyography and diaphragmatic ultrasound, thoracoabdominal synchrony assessed with plethysmographic bands, dyspnea, stridor, oxygen saturation, transcutaneous carbon dioxide value, blood pressure, heart rate and respiratory rate.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Madrid, 28041, Spain
Lower airway stenosis results in increased work of breathing with stridor and dyspnea, as a consequence of the increased resistances caused by the reduction in airway diameter. Airway resistance also depends on the length of the airway and the type of gas flow. Heliox (a mixture of Helium and Oxygen) is a gas less dense than air, which can change the flow from turbulent to laminar, reducing airway resistance by 20 to 40%, and therefore decreasing the work of breathing. Heliox is an inert gas that does not react with biological membranes, so there are few complications associated with its use, the most relevant being hypoxemia when fixed mixtures are not used and the the fraction of inspired oxygen (FiO2) supplied is less than 21%. The aim of the study was to evaluate if during the perioperative period of lower airway stenosis the administration of Heliox compared to oxygen could reduce the work of breathing and improve dyspnea. For this purpose, patients were treated for 30 minutes with Heliox (fixed mixture of 70% helium and 30% oxygen) using a non rebreather mask or reservoir bag versus 30 minutes with oxygen 31% using a Venturi mask.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Treatment for 30 minutes with Heliox from a commercial tank (Oxhelⓒ, Air Liquideⓒ) with a fixed mixture of 70% helium and 30% oxygen with non-rebreather mask or reservoir bag at a flow of 12-15 lpm.
Other names: Helium - Oxygen
Treatment for 30 minutes with oxygen at FiO2 of 31% with Venturi mask.
Other names: Oxygen 31%
Time frame: 30 minutes with Heliox and 30 minutes with Oxygen 31%
Percentage over the Root Mean Square peak for parasternal electromyography (EMG): averaged of the square root of the peak value and the area under the curve of parasternal EMG (%RootMeanSquare) adjusted for respiratory frequency, as a surrogate of diaphragmatic EMG, and sternocleidomastoid EMG, which will give us information on accessory muscle activation.
Time frame: At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
Assessment of muscular effort by measuring the diaphragmatic excursion (mm) at tidal volume and at vital capacity.
Time frame: At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
Assessment of muscular effort by measuring the thickening fraction of the diaphragm in the apposition zone (%).
Time frame: Phase angle was calculated from 10 consecutive breaths at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Assessment of thoracoabdominal synchrony using thoracic and abdominal belts by calculating the phase angle with the Lissajoux loop method (plotting abdominal motion on the x-axis against thoracic motion on the y-axis).
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Degree of dyspnea will be determined by this validated scale with a result between 1 and 10 points.0: Not at all 0.5: Very, very light (hardly noticeable) 1: Very light, 2: Light, 3: Moderate , 4: Somewhat intense, 5: Intense, 6: Between 5 and 7, 7: Very intense, 8: Between 7 and 9, 9: Very, very intense (almost maximum ), 10: Maximum
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Measured by pulse-oximetry
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Transcutaneous monitor uses a noninvasive technique to measure the skin-surface partial pressure of carbon dioxide (PtcCO2)
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Non-invasive measurement with a sphygmomanometer
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
number of beats per minute
Time frame: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Number of breaths per minute
Looking for future studies?
Notify MeHospital Universitario 12 de Octubre
Other
The Effect of Heliox on the Work of Breathing in Adult Patients With Lower Airway Stenosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07809399
Airway Obstruction, Chronic Disease
Al Mansurah, Dakahlia Governorate, Egypt
View Trial DetailsNCT06227234
Airway Obstruction, Choking
Calgary, Alberta, Canada
View Trial DetailsNCT06742476
Airway Obstruction, Respiration Disorders
Al Fayyum, Egypt
View Trial DetailsNCT06609499
Airway Obstruction, Respiration Disorders
Radom, Masovian Voivodeship, Poland
View Trial Details